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Abstract: Plantaricin 423, produced by Lactobacillus plantarum, and bacteriocin ST4SA 
produced  by  Enterococcus  mundtii,  were  electrospun  into  nanofibers  prepared  from 
different  combinations  of  poly(D,L-lactide)  (PDLLA)  and  poly(ethylene  oxide)  (PEO) 
dissolved  in  N,N-dimethylformamide  (DMF).  Both  peptides  were  released  from  the 
nanofibers with a high initial burst and retained 88% of their original antimicrobial activity 
at 37 ° C. Nanofibers have the potential to serve as carrier matrix for bacteriocins and open 
a  new  field  in  developing  controlled  antimicrobial  delivery  systems  for 
various applications.  
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1. Introduction 
Bacteriocins  (ribosomally  synthesized  antimicrobial  peptides)  and  bacteriocin-like  inhibitory 
substances  (BLIS)  are  produced  by  several  species  of  bacteria,  including  lactic  acid  bacteria  
that  are  generally  recognized  as  safe  [1–3].  Bacteriocins  are  diverse  peptides  and  can  be  
divided into the Class I (lanthionine-containing post-translationally modified bacteriocins), Class II  
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(non-lanthionine-containing bacteriocins that do not undergo extensive post-translational modification) 
and the bacteriolysins [1]. Each of these groups can be further sub-divided. Bacteriocins are membrane 
active peptides and most form pores in the cell membranes of sensitive bacteria due to the cationic and 
amphiphilic nature of these peptides, however there are exceptions [4]. Pore formation leads to the 
disruption of the proton motive force (PMF) and the efflux of intracellular material [5]. Bacteriocins 
can have a narrow (active against closely related species) or broad spectrum of activity [6,7]. Class Ia 
bacteriocins, or lantibiotics, use lipid II as target for their mode of action and kill sensitive bacteria by 
pore formation or by hampering cell wall formation [8]. Lantibiotics can also inhibit the germination 
of spores [8] Class IIa, or pediocin-like bacteriocins, mainly form pores in the membranes of sensitive 
cells [1]. By disrupting the PMF, cells cannot secrete antibiotics via transport systems located in their 
cell membranes. This could be an important answer to our search towards more effective ways of 
infection control. More than 95% of Staphylococcus aureus isolates are resistant to penicillin. Of 
these, 60 to 70% are resistant to methicillin [9]. 
A  few  bacteriocins  are  active  against  methicillin-resistant  strains  of  Staphylococcus  aureus 
(MRSA), and versus other bacteria of interest in human health, such as Pseudomonas aeruginosa, 
Streptococcus  pneumonia  and  vancomycin-resistant  enterococci  [10,11].  Bacteriocin  ST4SA, 
produced by Enterococcus mundtii, is a Class IIa bacteriocin and is active against several pathogens, 
including  Acinetobacter  baumannii,  Pseudomonas  aeruginosa,  Streptococcus  pneumonia, 
Staphylococcus aureus and Enterococcus faecium [5]. Bacteriocin ST4SA survived conditions in the 
human  and  animal  gastro-intestinal  tract  [12,13]  and  was  constitutively  expressed  [14].  Nisin  F, 
produced by Lactococcus lactis, was effective in the treatment of Staphylococcus aureus in respiratory 
tract infections  [15]. Plantaricin 423, produced by  Lactobacillus plantarum, displaced  Clostridium 
sporogenes  and  Enterococcus  faecalis  from  Caco-2  cells  [16].  Plantaricin  423  is also  a  Class  IIa 
bacteriocin and shows activity against Bacillus cereus, Clostridium sporogenes, Enterococcus faecalis, 
Lactobacillus  brevis  (Lactobacillus  spp.),  Listeria  innocua,  Listeria  monocytogenes, 
Propionibacterium  sp.,  Propionibacterium  acidipropionic  and  Staphylococcus  carnosum  [17]. 
Bacteriocins may thus offer an alternative to control bacterial infections, administered alone or in 
combination  with  antibiotics  [5].  The  challenge  would  be  to  protect bacteriocins  from  proteolytic 
enzymes, keep the peptides in contact with the infected surface and extend the contact time for as long 
as possible. 
Electrospun  nanofibers,  prepared  from  selected  polymers,  may  be  used  as  carrier  matrix  for 
bacteriocins and other antimicrobial peptides [18]. Nanofibers have been used to release antibiotics, 
proteins, growth factors, silver nanoparticles, plasmid DNA, as well as viable cells [18–26]. Specific 
structures can be designed, such as oxygen permeable membranes, matrices with a high surface to 
volume ratio and scaffolds that are morphologically similar to the extracellular matrix of skin [27–31]. 
In this paper we studied the feasibility of electrospinning bacteriocins into nanofibers, as well as 
investigating  the  nanofibers  as  a  delivery  system.  Plantaricin  423  and  bacteriocin  ST4SA  were  
used  as  model  bacteriocins  (Class  IIa)  in  this  study.  These  bacteriocins  were  dissolved  in  
N,N-dimethylformamide  (DMF)  and  electrospun  into  biodegradable  nanofiber  blends  of  
poly(D,L-lactide) (PDLLA) and poly(ethylene oxide) (PEO). The nanofiber scaffolds were evaluated 
(in vitro) for the release of the peptides and antimicrobial activity. Int. J. Mol. Sci. 2011, 12                       
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2. Results 
2.1. Electrospinning of Nanofibers 
Nanofibers produced from blends of PDLLA and PEO, containing plantaricin 423, have a regular 
texture and smooth surface, as revealed by scanning electron microscopy (SEM, Figure 1). The PEO 
90:PDLLA 10 blend produced fibers ranging from 200 to 450 nm, with most of the fibers in the  
300–350  nm  range  (Figure  1F).  Fibers  with  similar  dimensions  were  produced  from  the  PEO 
50:PDLLA 50 blend (Figure 1D). Fibers with slightly less variation (200–400 nm) and mostly in a 
smaller size range (250–300 nm) were produced from the PEO 70:PDLLA 30 blend (Figure 1E). 
Figure 1. SEM images of electrospun nanofibers containing plantaricin 423 (A–C) and 
fiber  diameter  distributions  of  the  electrospun  nanofibers  (D–F).  (A  and  D)  PEO 
50:PDLLA 50, (B and E) PEO 70:PDLLA 30, (C and F) PEO 90:PDLLA 10. 
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2.2. Fluorescent Microscopy Images of Polymers 
Fluorescent microscopy images have shown that PEO and PDLLA are homogenously distributed in 
the  fiber  structure  and  indicate  a  large  degree  of  miscibility  when  used  in  a  50:50  combination  
(Figure 2). This blend was selected based on characteristics best suited for a drug delivery system, as 
discussed in this manuscript. 
Figure  2.  Fluorescent  images  of  PEO  and  PDLLA  labeled  with  RBITC  and  FITC, 
respectively. (A) Fluorescent image of PEO; (B) fluorescent image of PDLLA; (C) overlay 
of  the  fluorescent  signals;  (D)  optical  image  of  fibers  with  fluorescent  signals;  
(E) co-localization of the two signals, indicating miscibility between PEO and PDLLA. 
   
   
   
2.3. DSC Analysis 
It can be seen that the DSC curve of the PEO 50:PDLLA 50 blend yielded a single glass transition 
temperature (Tg) of 9 ° C, which falls between the Tg values recorded for PEO (−54 ° C) and PDLLA 
(49  ° C)  (Figure  3).  DSC  curves  provide  a  good  indication  of  the  macromolecular  nature  of  the 
polymer,  i.e.,  crystallinity,  Tg  and  crystalline  melting  point.  In  our  study,  PDLLA  had  no  melt 
endothermic response as expected from an amorphous polymer, contrary to PEO where a melting 
endotherm was recorded at 64 ° C. From the insert in Figure 3, it is evident that a single Tg was 
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detectible at 9 ° C, which falls between both Tgs of PEO (−54 ° C) and PDLLA (49 ° C). It is therefore 
suggested that the blend is miscible in the amorphous phase. DSC analysis was also performed on the 
PEO 50:PDLLA 50 blend, containing plantaricin 423, and the Tg value decreased from 9 ° C (in the 
blend without peptide) to −12 ° C (data not shown). This Tg was still between that of the component 
polymers and therefore also suggested to be miscible in the amorphous phase. 
Figure 3. Differential scanning calorimetric (DSC) thermogram of the PEO 50:PDLLA 50 
blend, as well as the component polymers, PEO and PDLLA. 
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2.4. Fluorescent Images of Labeled Polymers and Peptide 
Fluorescently  labeled  plantaricin  423  was  electrospun  into  nanofibers  prepared  from  a  PEO 
50:PDLLA 50 blend. The bacteriocin was unevenly distributed in these fibers, indicating that the 
peptide has better interaction with one of the polymers (data not shown). Due to the amphiphilic nature 
of bacteriocins, we expected the peptide to show better association with one of the two polymers. 
Fluorescent images of nanofibers prepared from a PEO 50:PDLLA 50 blend are shown in Figure 4. 
Signals of the plantaricin 423 and PEO are overlapping (Figure 4C), suggesting that the peptide is 
associated with the polymer. This was verified with the co-localization of the signals (Figure 4E). 
These results were confirmed with fluorescent images of labeled plantaricin 423 and PDLLA. Green 
and red fluorescent signals could still be differentiated in the overlay, indicating that the peptide is 
closer associated with PEO. These results were supported with much less co-localization seen between 
the signals from the fluorescently labeled PDLLA and plantaricin 423 (Figure 4J). 
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Figure  4. Fluorescent images of labeled plantaricin 423 and polymers electrospun into 
nanofibers consisting of PEO 50:PDLLA 50. (A) Fluorescent image of PEO labeled with 
RBITC in the fibers; (B) fluorescent image of the bacteriocin labeled with FITC in the 
fibers; (C) overlay of the fluorescent images; (D) optical image of fibers with fluorescent 
signals; (E) co-localization of the signals; (F) fluorescent image of bacteriocin labeled with 
RBITC  in  the  fibers;  (G)  fluorescent  image  of  PDLLA  labeled  with  FITC  in  the  
fibers;  (H)  overlay  of  the  two  fluorescent  images;  (I)  optical  image  of  fibers  with 
fluorescent signals; (J) co-localization of the two signals. 
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2.5. Release of Antimicrobial Peptide 
From cumulative release studies, it is evident that the PEO 90:PDLLA 10 blend released the highest 
concentration (78%) of the antimicrobial peptides (Figure 5). An initial release of 46% was recorded 
within the first 2 h, followed by 32% over the following 8 days (Figure 5). This could be ideal in the 
control of infections. A rapid release of antimicrobial peptides during the first 2 h would kill most of 
the pathogens, whereas a slow and constant release over the following few days would keep infection 
under control. The PEO 70:PDLLA 30 and PEO 50:PDLLA 50 blends yielded less promising results 
with 69% and 60% of the peptides being released over 8 days (Figure 5). 
Figure 5. Cumulative release of plantaricin 423 from electrospun PEO:PDLLA blends. 
These fibers showed a high initial burst release and a more sustained release of bacteriocin 
over an 8 days period. 
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2.6. Morphological Changes and Weight Loss 
SEM images taken from PEO 50:PDLLA 50 nanofibers, containing plantaricin 423, after 8 days of 
incubation  in  PBS  buffer  (pH  7.4)  did  not  reveal  any  significant  structural  changes  or  signs  of 
deterioration of the fibrous structure (Figure 6I–L), suggesting that these nanofiber scaffolds would be 
stable for at least 8 days. Slight textural changes have been recorded for the PEO 70:PDLLA 30 blend, 
containing plantaricin 423, after 8 days (Figure 6E–H). However, significant morphological changes 
and signs of deterioration were observed for nanofibers prepared from the PEO 90:PDLLA 10 blend, 
containing  plantaricin  423  (Figure  6A–D).  Fibrous  structures  were  visible,  but  most  of  the  fibers 
formed a film-like structure after 2 h. 
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Figure 6. SEM images of PEO:PDLLA blend fibers, containing plantaricin 423, incubated 
in PBS buffer pH 7.4 for different time intervals. Significant morphological changes are 
seen in the PEO 90:PDLLA 10 blend (A–D). The PEO 70:PDLLA 30 blend showed some 
morphological changes; however the fiber structure stayed more or less intact (E–H). The 
PEO 50:PDLLA 50 blend showed very little morphological changes and the fiber structure 
stayed intact (I–L).  
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Nanofibers prepared from the PEO 90:PDLLA 10 blend showed high weight loss within the first 
few hours with only 24% of the original weight remaining. Eighty percent weight loss was seen over  
8 days at 37 ° C, whereas nanofibers prepared from the PEO 70:PDLLA 30 and PEO 50:PDLLA 50 
blends lost approximately 60% and 40% of their original weight, respectively (data not shown). 
2.7. Antimicrobial Activity Tests  
A clear zone of growth inhibition was recorded surrounding PEO 50:PDLLA 50 nanofibers for at 
least 6 days (Figure 7). This suggested that the nanofibers retained their antimicrobial activity for at 
least 6 days on solid medium. The peptides retained 88% of their original antimicrobial activity after 
18 h of incubation at 37 ° C in PBS pH 7.4. As little as 25 mg nanofibers inhibited the growth of  
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E. faecium HKLHS in 50 mL MRS broth for up to 10 h, whilst cells in the control (without nanofibers) 
reached stationary phase after 10 h (Figure 8). 
Figure  7.  Antimicrobial  activity  tests  of  PEO  50:PDLLA  50  blend  fibers  containing 
plantaricin  423  (A)  and  bacteriocin  ST4SA  (B).  Modified  Kirby  Bauer  tests  were 
performed by placing approximately 1 cm
2 of fiber on plates seeded with target strains. 
Enterococcus faecium HKLHS and Listeria monocytogenes EGD-e served as target strains 
for plantaricin 423 and for bacteriocin ST4SA, respectively. A clear zone of inhibition can 
be seen surrounding the fibers containing bacteriocins after incubation. 1: PEO 50:PDLLA 
50 blend fibers containing plantaricin 423, 2: PEO 50:PDLLA 50 blend fibers without 
plantaricin 423, 3: PEO 50:PDLLA 50 blend fibers containing bacteriocin ST4SA, 4: PEO 
50:PDLLA 50 blend fibers without bacteriocin ST4SA. 
   
Figure  8. Growth inhibition of  Enterococcus faecium  HKLHS by PEO 50:PDLLA 50 
blend nanofibers releasing plantaricin 423. 
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3. Experimental Section 
3.1. Isolation of Antimicrobial Peptides 
Lactobacillus plantarum 423 and Enterococcus mundtii ST4SA were cultured, separately, in MRS 
broth (Biolab, Biolab Diagnostics, Midrand, South Africa) for 24 h at 37 ° C. Cells were harvested 
(8000×  g, 10 min, 4 ° C), the pH of the cell-free supernatant adjusted to between pH 6.5–7.0 with  
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10 M NaOH and then heated at 80 ° C for 10 min to inactivate proteolytic enzymes. Peptides were 
precipitated from the cell-free supernatant with 70% saturated ammonium sulfate [32] and desalted 
against distilled water by using a 1000 Da cut-off dialysis membrane (Spectrum Inc., CA, USA). 
Protein concentrations were determined by using the Micro-bicinchoninic Acid (BCA) kit (Pierce, 
Rockford, IL). Readings were recorded at 562 nm. Samples were freeze-dried and stored at −20 ° C. 
3.2. Electrospinning of Nanofibers 
Freeze-dried peptides were dissolved in N,N-dimethylformamide (DMF) and centrifuged (6000×  g, 
1 min) to obtain the supernatants. From each of these supernatants, 2 mL was used as solvent for 
PDLLA  (20–24%,  w/v,  Sigma-Aldrich)  blended  with  poly(ethylene  oxide)  (PEO,  200,000  Da,  
Sigma-Aldrich) at a ratio of 10:90, 30:70 and 50:50, respectively. Solutions were heated to 40 ° C on a 
hot plate and then electrospun using a gravity system described by [20]. A constant electric field of  
+10 kV was applied to the polymer solution and −5 kV to the collector. The collector was placed 
15 cm from the polymer solution. The relative humidity was kept constant between 50–55%. 
3.3. Scanning Electron Microscopy of Electrospun Fibers  
Images  of  the  nanofibers  were  recorded  with  a  Leo
®  1430VP  Scanning  Electron  Microscope 
(SEM). Samples were coated with a thin layer of gold to increase conductivity. Fiber diameter was 
determined by using the SEM Image Studio Software (version 10.1). 
3.4. Fluorescent Labeling of Antimicrobial Peptides and Polymers 
Freeze-dried plantaricin 423 (20 mg) was suspended in 1 mL DMF and the supernatant was reacted 
with  20  mg  rhodamine  B  isothiocyanate  (RBITC)  or  fluorescein  isothiocyanate  (FITC)  from  
Sigma-Aldrich,  dissolved  in  the  same  volume.  The  solution  was  placed  on  an  orbital  shaker  and 
incubated in the dark at 4 ° C for 48 h. Unbound fluorescent marker was removed by dialyzing against 
sterile distilled water for 3 weeks at 4 ° C. Dialyses bags with 1000 Da cut-off (Spectrum Inc., CA, 
USA)  were  used.  Labeled  peptides  were  freeze-dried,  dissolved  in  DMF  and  electrospun  into 
nanofibers as described before. 
PEO (0.2048 mg) was dissolved in 2 mL sterile distilled water containing RBITC (20 mg/mL). The 
polymer solution was placed on an orbital shaker and incubated in the dark at 25 ° C for 48 h. Unbound 
fluorescent  marker  was  removed  through  dialysis  as  described  before  and  freeze-dried.  PDLLA 
(0.2048 mg) was dissolved in 2 mL DMF and was labeled with FITC (20 mg/mL) for 48h on an orbital 
shaker and incubated in the dark at 25 °C . 
The labeled peptides and polymer solution were electrospun into nanofibers as described before. 
Nanofibers were excited at 472 nm and 572 nm, respectively, by using a Xenon-Arc burner light 
source (Olympus Biosystems GMBH). Fluorescent images were captured with an Olympus Cell^
R 
system attached to an IX-81 inverted fluorescent microscope. An Olympus Plan Apo N 60× /1.4 Oil 
objective was used. Images were taken with an F-view-II cooled CCD camera (Soft Imaging Systems) 
and the background subtracted using the Cell^
R imaging software. 
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3.5. Differential Scanning Calorimetry (DSC) 
Thermal analysis was carried out with a TA Q100 Differential Scanning Calorimeter (DSC) (TA 
Instruments) which  was calibrated against  an indium standard. An empty  aluminium pan  was the 
reference.  Fiber  samples  (15–18  mg)  were  run  at  a  10  ° C/min  in  three  cycles  under  nitrogen 
atmosphere (flow rate 50 mL/min). In the first cycle, samples were heated from −80 °C  to 180 ° C and 
isothermed for 1 min; cooled back to −80 ° C and isothermed for 5 min. Finally, the samples were 
heated for a second time at 10 ° C/min to 180 ° C. The crystalline melting temperature (Tm) and the 
glass transition temperature (Tg) were recorded in the second heating cycle. 
3.6. Release of Antimicrobial Peptides and Degradation of Nanofibers 
Nanofibers (25  mg)  were  placed in 2 mL sterile  phosphate buffered  saline (PBS, pH 7.4)  and 
incubated at 37 ° C on an orbital shaker (30 rpm). At pre-determined time intervals the PBS was 
replaced with 2 mL sterile PBS (pH 7.4). The protein concentration in each sample was determined by 
using the BCA protein assay kit as described before. The concentration of bacteriocin in the nanofibers 
was determined by dissolving 25 mg fibers in DMF. This suspension was diluted in PBS 7.4 before the 
protein  concentration  was  determined  by  using  the  BCA  protein  assay  kit  as  described  before. 
Nanofibers  were  freeze-dried  and  then  visualized  by  SEM.  Changes  in  the  weight  of  nanofibers 
were recorded. 
3.7. Antimicrobial Activity Tests 
In a separate experiment, 25 mg of PEO 50:PDLLA 50 nanofibers containing plantaricin 423 was 
placed  in  50  mL  MRS  broth,  inoculated  with  Enterococcus  faecium  HKLHS  (10
5  cfu/mL)  and 
incubated at 37 ° C for 12 h. Changes in optical density readings were recorded at 600 nm. 
4. Discussion 
Electrospinning is a versatile technique to produce large amounts of fibers, in the micrometer to 
nanometer  range,  in  a  short  amount  of  time.  A  variety  of  natural  and  synthetic  polymers  have 
been electrospun  into  fibers  and  some  have  been  used  to  control  the  release  of  various  
compounds [13,19,22,26,31,33]. Blending hydrophilic and hydrophobic polymers directly in a suitable 
solvent before electrospinning, is an easy way to change the hydrophobicity, thermal stability and 
mechanical  strength  of  the  fibers  [34].  Since  blending  is  an  attractive  way  to  modify  polymer 
properties, this method was chosen to modify the hydrophobicity/hydrophilicity of the electrospun 
fibers by the addition of PEO, to help facilitate the release of the bacteriocin from the nanofibers.  
Fibers  were  all  in  the  nanometer  range  and  addition  of  bacteriocin  did  not  influence  the  fiber 
structure as can be seen in Figure 1. 
Polymers  were  labeled  to  elucidate  fiber  morphologies  after  electrospinning.  Fluorescent 
microscopy images showed that there is a large degree of miscibility between the PEO and PDLLA 
when these polymers are used in a 50:50 combination (Figure 2). However, to confirm these results 
and to determine the miscibility of the polymers, DSC analysis was performed on the PEO 50:PDLLA 
50 fiber blend, see Figure 3. This fiber blend was chosen as it retained its structure the best, had the Int. J. Mol. Sci. 2011, 12                       
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least amount of weight loss and still released enough bacteriocin to inhibit the growth of a sensitive 
strain. Nijenhuis et al. [34] have studied thermal properties using DSC of polymer blends containing 
various ratios of PEO and the poly L-lactide (PLLA) isomer. The results showed that blends containing 
up  to  50  wt%  PEO  were  miscible  in  the  amorphous  phase.  In  this  work,  PDLLA  which  is  an 
amorphous grade unlike the semi crystalline poly (D-lactide) PDLA was used. A good indication of a 
miscible polymer blend is the shift of the Tg to a value between the Tgs of the pure polymers. The Tg 
value of a mixed phase is determined by the weight fraction of each polymer in that phase, and by the 
Tgs of the pure polymers. DSC curves of the second heating cycle of the PEO 50:PDLLA 50 blend and 
the corresponding homopolymers are shown in Figure 3. A single Tg (9 ° C) can be seen that is between 
the Tgs values for PEO (−54 ° C) and PDLLA (49 ° C) which suggests that the PEO 50:PDLLA 50 
blend is miscible in the amorphous phase. DSC analysis performed on the PEO 50:PDLLA 50 blend, 
containing  plantaricin  423,  revealed  that  the  Tg  value  still  fell  between  the  Tg  of  the  component 
polymers  and  is  therefore  still  miscible  to  an  extent.  It  could  be  due  to  the  peptide  that  is  more 
associated with the PEO domains or simply restricting chain mobility. Investigation of the distribution 
of bacteriocins in the final fiber structure after electrospinning could yield important information in 
designing polymeric drug delivery systems for these peptides. 
Fluorescent microscopy images revealed that the bacteriocin was better associated with PEO than 
with  PDLLA,  even  though  the  peptide  was  associated  with  both  these  polymers  (Figure  4). 
Bacteriocins are amphiphilic peptides with both hydrophilic and hydrophobic residues [1]. Because of 
this amphiphilic nature it is possible for the peptide to interact better with one polymer than with the 
other. These results indicate that the bacteriocin is better associated with the hydrophilic polymer, in 
this case PEO, but were also associated with the PDLLA to a lesser extent. This would explain the 
high initial burst release within the first few hours.  
Cumulative release studies revealed that fibers with a higher PEO content showed a higher release 
of the bacteriocin than those with a lower PEO content (Figure 5). An initial burst release was seen 
within 2 h, after which a more sustained release was seen. This could be an ideal release profile in the 
control of infections. A rapid release of antimicrobial peptides during the first 2 h would kill most of 
the pathogens, whereas a slow and constant release over the following few days would keep infection 
under control. The PEO 70:PDLLA 30 and PEO 50:PDLLA 50 blends released lower amounts of the 
peptide, with the PEO 70:PDLLA 30 and PEO 50:PDLLA 50 blends releasing 69% and 60% of the 
peptides, respectively (Figure 5). Blends of different polymers have earlier shown to facilitate the 
release of molecules from electrospun fibers. Lysozyme release from nanofibers was facilitated by 
blending PEO and poly(ε-caprolactone) (PCL), with a 90:10 blend releasing most of the lysozyme with 
a high initial burst release [22]. Higher concentrations of cytochrome C were also released from fibers 
consisting  of  poly(L-lactide)  PLLA  and  high  concentrations  of  both  poly(L-lysine)  (PLL)  and 
poly(ethylene imine) (PEI), respectively [26]. Fibers containing 50% PLL released most of the protein 
(75%) with a high initial burst release. 
SEM images revealed that as the PEO content increased, significant morphological changes can be 
seen as the incubation time increased (Figure 6) The PEO 90:PDLLA 10 blend showed the most 
significant morphological changes over the 8 day period. This could be due to the high content of PEO 
in the fibers as PEO swells readily in an aqueous environment and dissolves easily. The resulting 
destruction of the nanofiber scaffold explains the higher release of antimicrobial peptide as observed Int. J. Mol. Sci. 2011, 12                       
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over 8 days (Figure 5). Fibers retained their structure better in the PBS buffer (pH 7.4), as the PEO 
content in the fibers decreased. This can be observed in the PEO 50:PDLLA 50 blend, with this blend 
showing  no  significant  signs  of  structural  changes  or  deterioration  in  the  buffer  medium  
(Figure 6I–L). Slight structural changes were seen for the PEO 70:PDLLA 30 blend after 8 days 
(Figure 6E–H). These results suggest that the PEO 50:PDLLA 50 blend nanofibers would be stable for 
at least 8 days and show no significant signs of degradation. The ideal nanofiber drug delivery systems 
has to retain its structure, have high oxygen permeability, variable pore size and a high surface to 
volume ratio. Nanofibers prepared from the PEO 90:PDLLA 10 blend showed very high weight loss 
over the 8 days period, which is not very desirable. The PEO 70:PDLLA 30 showed lower weight loss, 
however the PEO 50:PDLLA 50 showed the best results and lost the least amount of its original 
weight. It is very important that the nanofiber scaffolds retain their integrity and with this in mind, the 
PEO 50:PDLLA 50 would be the preferred choice as drug delivery system in this work. 
Bacteriocins retained their activity after electrospinning and were able to inhibit the growth of a 
sensitive strain on solid media as well as in liquid broth (Figures 7 and 8). The bacteriocins showed 
activity on the solid media for at least 6 days of incubation. Growth inhibition in liquid broth was 
observed and may be obtained over longer periods of time by electrospinning higher concentrations of 
bacteriocin in the fibers, by using more fibers (weight), or by replacing the fibers in the broth with new 
fibers at certain time intervals. Only 25 mg of fibers, containing plantaricin 423, was able to inhibit 
actively growing cells of Enterococcus faecium HKLHS, indicating the potent antimicrobial effect of 
this bacteriocin. The difference in antimicrobial activity and release on solid media and in liquid broth 
gives an indication that there is a big difference in release profile on solid media and in a buffer/liquid 
medium. During release studies in a buffer medium, a high concentration gradient is created (such as 
in the case of the method used for determining release) by replacing the old buffer with new buffer at 
each sampling point. This can increase the rate of diffusion of the peptide from the nanofiber scaffold 
to  the  buffer  medium.  The  detection  limit  of  the  protein  assay  is  also  in  µ g/mL,  whereas  the 
bacteriocins can still be active at lower concentrations of ng/mL. However, the concentration gradient 
can be much lower on solid media, resulting in lower release profiles and thus leads to increased 
periods of antimicrobial activity. 
5. Conclusion 
Bacteriocins remained active after electrospinning into nanofiber scaffolds. This technique provides 
the option to electrospin high concentrations of antimicrobial peptides into nanofibers. The rate at 
which these peptides are released is controlled by selection of the correct combination of polymers. 
The  degradation  rate  and  mechanical  properties  of  PDLLA  can  be  improved  by  blending  with  a 
hydrophilic  polymer  such  as  PEO.  Antimicrobial  peptides  electrospun  into  nanofibers  may  have 
potential applications in the pharmaceutical and food industries to control microbial growth. 
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